CAF (Construcciones y Auxiliar de Ferrocarriles) is a leading global manufacturer of rolling stock and rail components, listed on the Madrid Stock Exchange (CAF.MC). With a market cap of approximately €2.5B, CAF fits squarely in the small-to-mid cap range and offers a compelling risk-reward profile in the rail and low-emission transport theme.
Thesis
CAF is riding a multi-year rail investment cycle driven by decarbonization policies, urban congestion, and infrastructure modernization. The company’s record backlog of €14.5B (as of Q1 2025) provides exceptional revenue visibility. CAF is also a pioneer in hydrogen fuel cell trains, with the first units entering service in Germany and Italy, positioning it for the next wave of zero-emission rail. Valuation is attractive at ~10x forward EBITDA, with improving margins and free cash flow generation.
12-Month Catalysts
- Backlog Conversion: The massive order book will convert to revenue, driving double-digit top-line growth in 2025-2026.
- Hydrogen Train Deployments: Expansion of hydrogen train pilots in Europe and potential orders from the UK and US.
- US Market Entry: CAF is bidding on several US transit contracts, leveraging its new facility in New York.
- Margin Expansion: Operational leverage and cost efficiencies should lift EBITDA margins from ~8% to 10%+.
Key Risks
- Execution Risk: Large, complex projects may face delays or cost overruns.
- Commodity Price Volatility: Steel and energy costs could pressure margins.
Valuation Summary
CAF trades at ~10x forward EBITDA, a discount to peers like Alstom (~12x) and Stadler (~13x). With expected EBITDA growth of 15-20% annually, the stock offers a PEG ratio below 1.0. A re-rating to 12x EBITDA would imply 20% upside.
Balance Sheet Summary
CAF has a net debt/EBITDA of ~1.5x, with ample liquidity (€1.2B in cash and undrawn credit lines). The company generates positive free cash flow and has a solid investment-grade profile.
Disclaimer: This is not financial advice. Investing involves risk, including loss of principal. Do your own research.